160 related articles for article (PubMed ID: 34482026)
1. MicroRNA-199b-3p suppresses malignant proliferation by targeting Phospholipase Cε and correlated with poor prognosis in prostate cancer.
Liu J; Quan Z; Gao Y; Wu X; Zheng Y
Biochem Biophys Res Commun; 2021 Oct; 576():73-79. PubMed ID: 34482026
[TBL] [Abstract][Full Text] [Related]
2. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
[TBL] [Abstract][Full Text] [Related]
3. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
Pan MZ; Song YL; Gao F
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway.
Zheng Y; Jin J; Gao Y; Luo C; Wu X; Liu J
Med Sci Monit; 2020 Jul; 26():e924328. PubMed ID: 32696762
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway.
Xi M; Cheng L; Hua W; Zhou YL; Gao QL; Yang JX; Qi SY
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1002-1011. PubMed ID: 30779066
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
[TBL] [Abstract][Full Text] [Related]
7. miR-101-3p and miR-199b-5p promote cell apoptosis in oral cancer by targeting BICC1.
Wang H; Guo Y; Mi N; Zhou L
Mol Cell Probes; 2020 Aug; 52():101567. PubMed ID: 32259627
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
[TBL] [Abstract][Full Text] [Related]
9. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of oxidized low-density lipoprotein receptor 1 correlates with decreased miR-106b-5p, miR-93-5p, miR-3129-5p, miR-199b-3p, and miR-4465, higher recurrence rate, and poor prognosis in ovarian cancer.
Liu J; Zeng Y; Zheng L
Histol Histopathol; 2023 Apr; 38(4):475-485. PubMed ID: 36264049
[TBL] [Abstract][Full Text] [Related]
11. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
[TBL] [Abstract][Full Text] [Related]
12. miR-103a-3p Suppresses Cell Proliferation and Invasion by Targeting Tumor Protein D52 in Prostate Cancer.
Ge J; Mao L; Xu W; Fang W; Wang N; Ye D; Dong Z; Guan H; Guan C
J Invest Surg; 2021 Sep; 34(9):984-992. PubMed ID: 32166986
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-373-3p inhibits prostate cancer progression by targeting AKT1.
Qu HW; Jin Y; Cui ZL; Jin XB
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6252-6259. PubMed ID: 30338790
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
16. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis.
Zhang D; Yang XJ; Luo QD; Xue L; Chong T
Cancer Gene Ther; 2022 Jul; 29(7):1001-1011. PubMed ID: 34799723
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer.
Liu J; Li J; Ma Y; Xu C; Wang Y; He Y
Bioengineered; 2021 Dec; 12(1):3240-3251. PubMed ID: 34238129
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
[TBL] [Abstract][Full Text] [Related]
20. MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4.
Hu CY; You P; Zhang J; Zhang H; Jiang N
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5133-5138. PubMed ID: 31298366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
